Drugs / DnaK
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01111279 | Mar → Sep 2010 | allergic disease | BioTech Tools S.A. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DnaK | “DnaK Immunoregulating Adjuvant” NCT01111279 ↗ |